El efecto de la depresión en la licencia por enfermedad remunerada producto de la enfermedad metabólica y cardiovascular en trabajadores con salarios bajos. (Depresión y licencia por enfermedad)
Publicado
may 19, 2022
Almetrics
Dimensions
Google Scholar
##plugins.themes.bootstrap3.article.details##
Resumen
Introducción: El sistema de salud colombiano permite que los trabajadores reclamen la licencia por enfermedad remunerada por condiciones de salud adversas, algunas de estas condiciones están relacionadas a la enfermedad metabólica y cardiovascular. Se ha encontrado una asociación entre la enfermedad metabólica y cardiovascular con la depresión. Sin embargo, el efecto de los trastornos del comportamiento, como la depresión, en el ausentismo laboral es desconocido en el mundo en desarrollo. El objetivo de esta investigación es estimar si los trabajadores de salarios bajos que sufren de depresión, enfermedad metabólica y enfermedad cardiovascular solicitan mayor cantidad de días de licencia remunerada, comparando este dato con personas con las mismas comorbilidades médicas pero sin depresión.
Keywords
cardiovascular disease, sick leave, health insurance, depression, endocrine system diseasesdoença cardiovascular, licença-médica, seguro de saúde, depressão, doenças do sistema endócrinoenfermedad cardiovascular, licencia remunerada, seguro de salud, depresión, enfermedades del sistema endocrino
References
1. Crisp R. Depression and occupational disability in five diagnostic groups: A review of recent research. Disabil Rehabil. 1 de enero de 2007;29(4):267-79. https://doi.org/10.1080/09638280600835267
2. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National multimorbidity Survey Replication (NCS-R). JAMA. 18 de junio de 2003;289(23):3095-105. Doi: https://doi.org/10.1001/jama.289.23.3095
3. Pandalai SP, Schulte PA, Miller DB. Conceptual heuristic models of the interrelationships between obesity and the occupational environment. Scand J Work Environ Health. 1 de mayo de 2013;39(3):221-32. Doi: https://doi.org/10.5271/sjweh.3363
4. Nigatu YT, Reijneveld SA, Penninx BWJH, Schoevers RA, Bültmann U. The longitudinal joint effect of obesity and major depression on work performance impairment. Am J Public Health. mayo de 2015;105(5):e80-86. . Doi: https://doi.org/10.2105/AJPH.2015.302557.
5. World Health Organization, Noncommunicable Disease and Mental Health Cluster. Investing in mental health. [Internet]. 2003 [cited 2022 Jan 26]. Available from: http://www.myilibrary.com?id=9723
6. Koopmans PC, Roelen CAM, Groothoff JW. Sickness absence due to depressive symptoms. Int Arch Occup Environ Health. mayo de 2008;81(6):711-9. Doi: https://doi.org/10.1007/s00420-007-0243-7
7. Burton WN, Chen C-Y, Schultz AB, Edington DW. The prevalence of metabolic syndrome in an employed population and the Impact on health and productivity. J Occup Environ Med. octubre de 2008;50(10):1139-48. Doi: https://doi.org/10.1097/JOM.0b013e318188b8eb.
8. Sullivan PW, Ghushchyan V, Wyatt HR, Wu EQ, Hill JO. Productivity costs associated with cardiometabolic risk factor clusters in the United States. Value Health J Int Soc Pharmacoeconomics Outcomes Res. diciembre de 2007;10(6):443-50. . Doi: https://doi.org/10.1111/j.1524-4733.2007.00199.x
9. Singh VK, Karmani S, Malo PK, Virupaksha HG, Muralidhar D, Venkatasubramanian G, et al. Impact of lifestyle modification on some components of metabolic syndrome in persons with severe mental disorders: A meta-analysis. Schizophr Res. 2018;202:17-25. Doi: https://doi.org/10.1016/j.schres.2018.06.066
10. Ohaeri JU, Akanji AO. Metabolic syndrome in severe mental disorders. Metab Syndr Relat Disord. abril de 2011;9(2):91-8. Doi: https://doi.org/10.1089/met.2010.0053. Doi: https://doi.org/10.1177/0003319718780145.
11. Manolis TA, Manolis AA, Manolis AS. Cardiovascular Safety of Psychiatric Agents: A Cautionary Tale. Angiology. febrero de 2019;70(2):103-29. Doi: https://doi.org/10.1177/0003319718780145
12. Druss BG, Marcus SC, Olfson M, Tanielian T, Elinson L, Pincus HA. Comparing the national economic burden of five chronic conditions. Health Aff Proj Hope. diciembre de 2001;20(6):233-41. Doi:https://doi.org/10.1377/hlthaff.20.6.233
13. Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet Lond Engl. 15 de diciembre de 2012;380(9859):2197-223. Doi: https://doi.org/10.1016/S0140-6736(12)61690-0
14. Depression [Internet]. [citado 15 de agosto de 2019]. Disponible en: https://www.who.int/news-room/fact-sheets/detail/depression
15. Kessler RC. The costs of depression. Psychiatr Clin North Am. marzo de 2012;35(1):1-14. Doi: https://doi.org/10.1016/j.psc.2011.11.005
16. Bielecky A, Chen C, Ibrahim S, Beaton DE, Mustard CA, Smith PM. The Impact of comorbid mental and physical disorders on presenteeism. Scand J Work Environ Health. noviembre de 2015;41(6):554-64. Doi: https://doi.org/10.5271/sjweh.3524.
17. Evans-Lacko S, Knapp M. Global patterns of workplace productivity for people with depression: absenteeism and presenteeism costs across eight diverse countries. Soc Psychiatry Psychiatr Epidemiol. 2016;51(11):1525-37. Doi: https://doi.org/10.1007/s00127-016-1278-4.
18. Murray CJL, Lopez AD, Organization WH, Bank W, Health HS of P. The Global burden of disease : a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 : summary [Internet]. World Health Organization; 1996 [citado 20 de agosto de 2019]. Disponible en:https://apps.who.int/iris/handle/10665/41864. Doi:
19. Uribe JM, Pinto DM, Vecino-Ortiz AI, Gómez-Restrepo C, Rondón M. Presenteeism, Absenteeism, and Lost Work Productivity among Depressive Patients from Five Cities of Colombia. Value Health Reg Issues. diciembre de 2017;14:15-9. https://doi.org/10.1016/j.vhri.2017.03.001
20. Angstman KB, Meunier MR, Rohrer JE, Oberhelman SS, Maxson JA, Rahman PAS. Future complexity of care tier affected by depression outcomes. J Prim Care Community Health. 1 de enero de 2014;5(1):30-5. Doi: https://doi.org/10.1177/2150131913511465
21. Rincon HG, Granados M, Unutzer J, Gomez M, Duran R, Badiel M, et al. Prevalence, detection and treatment of anxiety, depression, and delirium in the adult critical care unit. Psychosomatics. octubre de 2001;42(5):391-6. Doi: https://doi.org/10.1176/appi.psy.42.5.391
22. Rincon-Hoyos HG, Castillo A, Prada SI. Alcohol use disorders and psychiatric diseases in Colombia. Colomb Medica Cali Colomb. 30 de marzo de 2016;47(1):31-7. Doi: https://doi.org/10.25100/cm.v47i1.1991
23. O'Neil A, Williams ED, Stevenson CE, Oldenburg B, Sanderson K. Co-morbid depression is associated with poor work outcomes in persons with cardiovascular disease (CVD): a large, nationally representative survey in the Australian population. BMC Public Health. 18 de enero de 2012;12:47. . Doi: https://doi.org/10.1186/1471-2458-12-47
24. Waghorn G, Chant D, Lloyd C. Labor force activity among Australians with musculoskeletal disorders comorbid with depression and anxiety disorders. J Occup Rehabil. junio de 2006;16(2):241-52.
25. Depression as a Systemic Illness [Internet]. Oxford University Press; [citado 20 de agosto de 2019]. Disponible en: https://oxfordmedicine.com/view/10.1093/med/9780190603342.001.0001/med-9780190603342
26. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. enero de 2008;9(1):46-56. Doi: https://doi.org/10.1038/nrn2297
27. Janssen DGA, Caniato RN, Verster JC, Baune BT. A psychoneuroimmunological review on cytokines involved in antidepressant treatment response. Hum Psychopharmacol. abril de 2010;25(3):201-15. Doi: https://doi.org/10.1371/journal.pone.0194029
28. Arango-Dávila CA, Rincón-Hoyos HG. Depressive Disorder, Anxiety Disorder and Chronic Pain: Multiple Manifestations of a Common Clinical and Pathophysiological Core. Rev Colomb Psiquiatr. marzo de 2018;47(1):46-55. . Doi: https://doi.org/10.1016/j.rcpeng.2017.12.003
29. Leonard B, Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev. febrero de 2012;36(2):764-85. Doi: https://doi.org/10.1016/j.neubiorev.2011.12.005
30. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 1 de mayo de 2009;65(9):732-41. Doi: https://doi.org/10.1016/j.biopsych.2008.11.029
31. Slavich GM, Irwin MR. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull. mayo de 2014;140(3):774-815. https://doi.org/10.1037/a0035302
32. Ervasti J, Vahtera J, Pentti J, Oksanen T, Ahola K, Kivekäs T, et al. Return to work after depression-related absence by employees with and without other health conditions: a cohort study. Psychosom Med. marzo de 2015;77(2):126-35. Doi: https://doi.org/10.1097/PSY.0000000000000138
33. Wysokiński A, Strzelecki D, Kłoszewska I. Levels of triglycerides, cholesterol, LDL, HDL and glucose in patients with schizophrenia, unipolar depression and bipolar disorder. Diabetes Metab Syndr. septiembre de 2015;9(3):168-76. Doi: https://doi.org/10.1016/j.dsx.2015.04.004
34. WHO | Depression and Other Common Mental Disorders [Internet]. WHO. [citado 20 de agosto de 2019]. Disponible en: http://www.who.int/mental_health/management/depression/prevalence_global_health_estimates/en/
35. Sistema Integral de Información SISPRO [Internet]. [citado 20 de agosto de 2019]. Disponible en: https://www.minsalud.gov.co/salud/Paginas/SistemaIntegraldeInformaci%C3%B3nSISPRO.aspx
36. Pinto Masís D, Gómez-Restrepo C, Uribe Restrepo M, Miranda C, Pérez A, de la Espriella M, et al. La carga económica de la depresión en Colombia: costos directos del manejo intrahospitalario. Rev Colomb Psiquiatr. septiembre de 2010;39(3):465-80. Doi: https://doi.org/10.1016/S0034-7450(14)60219-5
37. Rincón HG. COGNITIVE MEDICINE: AN ECOLOGICAL MODEL. Rev Colomb Psiquiatr. julio de 2003;32(3):260-6.
38. Derecho del Bienestar Familiar [RESOLUCION_MINPROTECCION_2646_2008] [Internet]. [citado 20 de agosto de 2019]. Disponible en: https://www.icbf.gov.co/cargues/avance/docs/resolucion_minproteccion_2646_2008.htm
39. Guía técnica general factor psicosocial.pdf [Internet]. Google Docs. [citado 20 de agosto de 2019]. Disponible en: https://drive.google.com/file/d/1pwrb6J4Rag-eo_dsL-YNlR06oCrkDxE9/view?usp=sharing&usp=embed_facebook
40. Duque CAO. Manual de procedimientos para la rehabilitación y reincorporación ocupacional. [citado 20 de agosto de 2019]; Disponible en: https://www.academia.edu/17308393/Manual_de_procedimientos_para_la_rehabilitaci%C3%B3n_y_reincorporaci%C3%B3n_ocupacional
41. Ortiz VHC, Prowesk KVS, Ortiz FA. Factores de riesgo psicosocial laboral: métodos e instrumentos de evaluación | Charria Ortiz | Facultad Nacional de Salud Pública. [citado 20 de agosto de 2019]; Disponible en: https://aprendeenlinea.udea.edu.co/revistas/index.php/fnsp/article/view/9715
42. World Health Organization. Prevention and Promotion in Mental Health.
43. Stenlund T, Ahlgren C, Lindahl B, Burell G, Steinholtz K, Edlund C, et al. Cognitively oriented behavioral rehabilitation in combination with Qigong for patients on long-term sick leave because of burnout: REST--a randomized clinical trial. Int J Behav Med. 2009;16(3):294-303. https://doi.org/10.1007/s12529-008-9011-7
44. World Health Organization. Prevention and Promotion in Mental Health.
2. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National multimorbidity Survey Replication (NCS-R). JAMA. 18 de junio de 2003;289(23):3095-105. Doi: https://doi.org/10.1001/jama.289.23.3095
3. Pandalai SP, Schulte PA, Miller DB. Conceptual heuristic models of the interrelationships between obesity and the occupational environment. Scand J Work Environ Health. 1 de mayo de 2013;39(3):221-32. Doi: https://doi.org/10.5271/sjweh.3363
4. Nigatu YT, Reijneveld SA, Penninx BWJH, Schoevers RA, Bültmann U. The longitudinal joint effect of obesity and major depression on work performance impairment. Am J Public Health. mayo de 2015;105(5):e80-86. . Doi: https://doi.org/10.2105/AJPH.2015.302557.
5. World Health Organization, Noncommunicable Disease and Mental Health Cluster. Investing in mental health. [Internet]. 2003 [cited 2022 Jan 26]. Available from: http://www.myilibrary.com?id=9723
6. Koopmans PC, Roelen CAM, Groothoff JW. Sickness absence due to depressive symptoms. Int Arch Occup Environ Health. mayo de 2008;81(6):711-9. Doi: https://doi.org/10.1007/s00420-007-0243-7
7. Burton WN, Chen C-Y, Schultz AB, Edington DW. The prevalence of metabolic syndrome in an employed population and the Impact on health and productivity. J Occup Environ Med. octubre de 2008;50(10):1139-48. Doi: https://doi.org/10.1097/JOM.0b013e318188b8eb.
8. Sullivan PW, Ghushchyan V, Wyatt HR, Wu EQ, Hill JO. Productivity costs associated with cardiometabolic risk factor clusters in the United States. Value Health J Int Soc Pharmacoeconomics Outcomes Res. diciembre de 2007;10(6):443-50. . Doi: https://doi.org/10.1111/j.1524-4733.2007.00199.x
9. Singh VK, Karmani S, Malo PK, Virupaksha HG, Muralidhar D, Venkatasubramanian G, et al. Impact of lifestyle modification on some components of metabolic syndrome in persons with severe mental disorders: A meta-analysis. Schizophr Res. 2018;202:17-25. Doi: https://doi.org/10.1016/j.schres.2018.06.066
10. Ohaeri JU, Akanji AO. Metabolic syndrome in severe mental disorders. Metab Syndr Relat Disord. abril de 2011;9(2):91-8. Doi: https://doi.org/10.1089/met.2010.0053. Doi: https://doi.org/10.1177/0003319718780145.
11. Manolis TA, Manolis AA, Manolis AS. Cardiovascular Safety of Psychiatric Agents: A Cautionary Tale. Angiology. febrero de 2019;70(2):103-29. Doi: https://doi.org/10.1177/0003319718780145
12. Druss BG, Marcus SC, Olfson M, Tanielian T, Elinson L, Pincus HA. Comparing the national economic burden of five chronic conditions. Health Aff Proj Hope. diciembre de 2001;20(6):233-41. Doi:https://doi.org/10.1377/hlthaff.20.6.233
13. Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet Lond Engl. 15 de diciembre de 2012;380(9859):2197-223. Doi: https://doi.org/10.1016/S0140-6736(12)61690-0
14. Depression [Internet]. [citado 15 de agosto de 2019]. Disponible en: https://www.who.int/news-room/fact-sheets/detail/depression
15. Kessler RC. The costs of depression. Psychiatr Clin North Am. marzo de 2012;35(1):1-14. Doi: https://doi.org/10.1016/j.psc.2011.11.005
16. Bielecky A, Chen C, Ibrahim S, Beaton DE, Mustard CA, Smith PM. The Impact of comorbid mental and physical disorders on presenteeism. Scand J Work Environ Health. noviembre de 2015;41(6):554-64. Doi: https://doi.org/10.5271/sjweh.3524.
17. Evans-Lacko S, Knapp M. Global patterns of workplace productivity for people with depression: absenteeism and presenteeism costs across eight diverse countries. Soc Psychiatry Psychiatr Epidemiol. 2016;51(11):1525-37. Doi: https://doi.org/10.1007/s00127-016-1278-4.
18. Murray CJL, Lopez AD, Organization WH, Bank W, Health HS of P. The Global burden of disease : a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 : summary [Internet]. World Health Organization; 1996 [citado 20 de agosto de 2019]. Disponible en:https://apps.who.int/iris/handle/10665/41864. Doi:
19. Uribe JM, Pinto DM, Vecino-Ortiz AI, Gómez-Restrepo C, Rondón M. Presenteeism, Absenteeism, and Lost Work Productivity among Depressive Patients from Five Cities of Colombia. Value Health Reg Issues. diciembre de 2017;14:15-9. https://doi.org/10.1016/j.vhri.2017.03.001
20. Angstman KB, Meunier MR, Rohrer JE, Oberhelman SS, Maxson JA, Rahman PAS. Future complexity of care tier affected by depression outcomes. J Prim Care Community Health. 1 de enero de 2014;5(1):30-5. Doi: https://doi.org/10.1177/2150131913511465
21. Rincon HG, Granados M, Unutzer J, Gomez M, Duran R, Badiel M, et al. Prevalence, detection and treatment of anxiety, depression, and delirium in the adult critical care unit. Psychosomatics. octubre de 2001;42(5):391-6. Doi: https://doi.org/10.1176/appi.psy.42.5.391
22. Rincon-Hoyos HG, Castillo A, Prada SI. Alcohol use disorders and psychiatric diseases in Colombia. Colomb Medica Cali Colomb. 30 de marzo de 2016;47(1):31-7. Doi: https://doi.org/10.25100/cm.v47i1.1991
23. O'Neil A, Williams ED, Stevenson CE, Oldenburg B, Sanderson K. Co-morbid depression is associated with poor work outcomes in persons with cardiovascular disease (CVD): a large, nationally representative survey in the Australian population. BMC Public Health. 18 de enero de 2012;12:47. . Doi: https://doi.org/10.1186/1471-2458-12-47
24. Waghorn G, Chant D, Lloyd C. Labor force activity among Australians with musculoskeletal disorders comorbid with depression and anxiety disorders. J Occup Rehabil. junio de 2006;16(2):241-52.
25. Depression as a Systemic Illness [Internet]. Oxford University Press; [citado 20 de agosto de 2019]. Disponible en: https://oxfordmedicine.com/view/10.1093/med/9780190603342.001.0001/med-9780190603342
26. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. enero de 2008;9(1):46-56. Doi: https://doi.org/10.1038/nrn2297
27. Janssen DGA, Caniato RN, Verster JC, Baune BT. A psychoneuroimmunological review on cytokines involved in antidepressant treatment response. Hum Psychopharmacol. abril de 2010;25(3):201-15. Doi: https://doi.org/10.1371/journal.pone.0194029
28. Arango-Dávila CA, Rincón-Hoyos HG. Depressive Disorder, Anxiety Disorder and Chronic Pain: Multiple Manifestations of a Common Clinical and Pathophysiological Core. Rev Colomb Psiquiatr. marzo de 2018;47(1):46-55. . Doi: https://doi.org/10.1016/j.rcpeng.2017.12.003
29. Leonard B, Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev. febrero de 2012;36(2):764-85. Doi: https://doi.org/10.1016/j.neubiorev.2011.12.005
30. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 1 de mayo de 2009;65(9):732-41. Doi: https://doi.org/10.1016/j.biopsych.2008.11.029
31. Slavich GM, Irwin MR. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull. mayo de 2014;140(3):774-815. https://doi.org/10.1037/a0035302
32. Ervasti J, Vahtera J, Pentti J, Oksanen T, Ahola K, Kivekäs T, et al. Return to work after depression-related absence by employees with and without other health conditions: a cohort study. Psychosom Med. marzo de 2015;77(2):126-35. Doi: https://doi.org/10.1097/PSY.0000000000000138
33. Wysokiński A, Strzelecki D, Kłoszewska I. Levels of triglycerides, cholesterol, LDL, HDL and glucose in patients with schizophrenia, unipolar depression and bipolar disorder. Diabetes Metab Syndr. septiembre de 2015;9(3):168-76. Doi: https://doi.org/10.1016/j.dsx.2015.04.004
34. WHO | Depression and Other Common Mental Disorders [Internet]. WHO. [citado 20 de agosto de 2019]. Disponible en: http://www.who.int/mental_health/management/depression/prevalence_global_health_estimates/en/
35. Sistema Integral de Información SISPRO [Internet]. [citado 20 de agosto de 2019]. Disponible en: https://www.minsalud.gov.co/salud/Paginas/SistemaIntegraldeInformaci%C3%B3nSISPRO.aspx
36. Pinto Masís D, Gómez-Restrepo C, Uribe Restrepo M, Miranda C, Pérez A, de la Espriella M, et al. La carga económica de la depresión en Colombia: costos directos del manejo intrahospitalario. Rev Colomb Psiquiatr. septiembre de 2010;39(3):465-80. Doi: https://doi.org/10.1016/S0034-7450(14)60219-5
37. Rincón HG. COGNITIVE MEDICINE: AN ECOLOGICAL MODEL. Rev Colomb Psiquiatr. julio de 2003;32(3):260-6.
38. Derecho del Bienestar Familiar [RESOLUCION_MINPROTECCION_2646_2008] [Internet]. [citado 20 de agosto de 2019]. Disponible en: https://www.icbf.gov.co/cargues/avance/docs/resolucion_minproteccion_2646_2008.htm
39. Guía técnica general factor psicosocial.pdf [Internet]. Google Docs. [citado 20 de agosto de 2019]. Disponible en: https://drive.google.com/file/d/1pwrb6J4Rag-eo_dsL-YNlR06oCrkDxE9/view?usp=sharing&usp=embed_facebook
40. Duque CAO. Manual de procedimientos para la rehabilitación y reincorporación ocupacional. [citado 20 de agosto de 2019]; Disponible en: https://www.academia.edu/17308393/Manual_de_procedimientos_para_la_rehabilitaci%C3%B3n_y_reincorporaci%C3%B3n_ocupacional
41. Ortiz VHC, Prowesk KVS, Ortiz FA. Factores de riesgo psicosocial laboral: métodos e instrumentos de evaluación | Charria Ortiz | Facultad Nacional de Salud Pública. [citado 20 de agosto de 2019]; Disponible en: https://aprendeenlinea.udea.edu.co/revistas/index.php/fnsp/article/view/9715
42. World Health Organization. Prevention and Promotion in Mental Health.
43. Stenlund T, Ahlgren C, Lindahl B, Burell G, Steinholtz K, Edlund C, et al. Cognitively oriented behavioral rehabilitation in combination with Qigong for patients on long-term sick leave because of burnout: REST--a randomized clinical trial. Int J Behav Med. 2009;16(3):294-303. https://doi.org/10.1007/s12529-008-9011-7
44. World Health Organization. Prevention and Promotion in Mental Health.
Cómo citar
Prada, S. I. ., Rincón-Hoyos , H. G., Pérez, A. M. ., Sierra-Ruiz, M., & Serna, V. . (2022). El efecto de la depresión en la licencia por enfermedad remunerada producto de la enfermedad metabólica y cardiovascular en trabajadores con salarios bajos. (Depresión y licencia por enfermedad). Gerencia Y Políticas De Salud, 21. https://doi.org/10.11144/Javeriana.rgps21.edps
Sección
Artículos
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.